Searchable abstracts of presentations at key conferences in endocrinology

ea0016p245 | Diabetes and cardiovascular diseases | ECE2008

Correlation between inflammation markers and plasma fasting glucose in overweight and obese women

Kutluturk Faruk , Bayraktaroglu Taner , Azezli Adil , Orhan Yusuf

Introduction: Elevated levels of the inflammatory markers are associated with increased risk for CVD and diabetes mellitus. There is accumulating evidence indicating that inflammatory markers as C-reactive protein (CRP) is associated with insulin resistance. The aim of the study is to evaluate the correlations between serum inflammatory markers and plasma fasting glucose (PFG) in overweight and obese women.Methods: Overweight (25<BMI<30 kg/m...

ea0016p518 | Obesity | ECE2008

Glomerular filtration rates as a cardiometabolic risk markers in obese women

Bayraktaroglu Taner , Kutluturk Faruk , Dogan Azezli Adil , Orhan Yusuf

Introduction: This study carried out relationship between glomerulary filtration rates (GFR) and various metabolic parameters in obese women.Materials and methods: Selected subjects recruited retrospectively from outpatient clinic for this study were 5115 overweight or obese women with mean GFR which was 93 ml/dk/1.73 m2 calculated by MDRD (modification of diet in renal disease). According to mean GFR, they divided group I (low GFR) having &#8...

ea0016p559 | Obesity | ECE2008

Relation of high-sensitive C-reactive protein and metabolic risk factors in overweight and obese women

Kutluturk Faruk , Bayraktaroglu Taner , Azezli Adil , Orhan Yusuf

Introduction: Elevated high-sensitive c-reactive protein (hs-CRP) in association with hyperinsulinemia, obesity, insulin resistance and high blood pressure are significant risk factors for cardiovascular diseases. The aim of this study is to evaluated the correlations between serum hs-CRP concentration and metabolic risk factors in overweight and obese women.Methods: Overweight (BMI>25 kg/m2) and obese (BMI>30 kg/m2) 755 wom...

ea0014p242 | (1) | ECE2007

Uric acid is an important predictor of metabolic disturbances in obese women

Cikim Ayse Sertkaya , Bayraktaroglu Taner , Azezli Adil Dogan , Orhan Yusuf

Introduction: It was shown that a relationship between uric acid and cardiovascular diseases, and hyperuricemia is associated with systemic inflammation. But, determination of uric acid is widely available and inexpensive, it has been overlooked as a marker of systemic inflammation and metabolic disturbances. In this study, we aimed to evaluate uric acid value and its association with inflammation and metabolic disturbances in overweight and obese Turkish women.<p class="a...

ea0014p400 | (1) | ECE2007

Relationship between antropometric and metabolic parameters and parathyroid hormone levels in women

Cikim Ayse Sertkaya , Bayraktaroglu Taner , Azezli Adil Dogan , Orhan Yusuf

Aim: Increased levels of fasting parathyroid hormone(PTH) have been hypothesized to influence increased levels of body fat mass. Preliminary studies show that serum PTH levels are higher in obese than in non-obese young adults and decline with weight loss. In the present study, it was aimed to evaluate relationship between antropometric and metabolic risk parameters and PTH levels in Turkish women.Materials and methods: Analyses were performed on 710 Tur...

ea0014p401 | (1) | ECE2007

Serum calcium levels and metabolic disturbances in obese women

Bayraktarogl Taner , Cikim Ayse Sertkaya , Azezli Adil Dogan , Orhan Yusuf

Aim: Serum calcium levels have a relation glucose homeostasis and weight management, and controversies in findings. This study carried out relationship between serum calcium levels and various metabolic parameters in obese Turkish Women.Materials and methods: Subjects for this study were 3544 overweight or obese Turkish women with mean level of serum calcium 9.4 md/dl. According to mean calcium level, they divided group I having >9.4 mg/dl and group ...

ea0014p635 | (1) | ECE2007

Age at menarche in relation to adult obesity

Bayraktaroglu Taner , Sertkaya Cikim Ayse , Dogan Azezli Adil , Orhan Yusuf

Introduction: Age at menarche reflects various health aspects including the timing of sexual maturation, growth and nutritional status, and enviromental conditions. This study carried out assesment obesity risk and the relationship between obesity, metabolic parameters and age at menarche in a series of Turkish women.Materials and methods: In a survey of obesity outpatient clinic, 4212 women who have mean age 38.5±12.1 years and ages at menarche bet...

ea0099p150 | Reproductive and Developmental Endocrinology | ECE2024

Prevalence of polycystic ovary syndrome in women with prediabetes

Sulu Cem , Ozkaya Hande , Damci Taner , Kelestimur Fahrettin , Gonen Mustafa

Objective: To determine the frequency of polycystic ovary syndrome (PCOS) in women with prediabetes compared to control women.Methods: Digital screening and tele-interviews remotely excluded 3218 out of 3465 consecutive women applied for routine check-up. In-person assessments were performed on 247 women, excluding 49. Final analyses included 198 premenopausal women without endocrine disorders (other than prediabetes and PCOS) or conditions affecting gon...

ea0090ep1025 | Thyroid | ECE2023

Clinical Significance of Basal and Stimulated Calcitonin Levels in A Case with Obesity Under Liraglutide Treatment

Bayraktaroğlu Taner , Yilmaz Doğancan , Tekin Sakin , Topaloğlu Omercan

Background: Liraglutide is a long-acting GLP-1 receptor (GLP-1R) agonist. GLP-1R is highly expressed in C-cells hyperplasia and in medullary thyroid cancer. We aimed to evaluate calcitonin levels stimulated by calcium test and possible development of C-cell hyperplasia during Liraglutide therapy in a case with obesity.Case Report: A 50-year-old woman was referred to endocrinology policlinic with complaints of increased appetite and weight gain. There wer...

ea0063p496 | Calcium and Bone 2 | ECE2019

A new and effective treatment option for challenging chronic hypoparathyroidism cases: Alternate-day dosing regimen

Akkan Tolga , Dagdeviren Murat , Or Koca Arzu , Ertugrul Derun Taner , Altay Mustafa

Objective: In chronic hypoparathyroidism, conventional therapy consists of oral calcium supplements and active vitamin D analogs but some patients cannot achieve treatment goals despite the high dose of oral calcium supplementation. Therefore, parathyroid gland transplantation and recombinant human PTH have been investigating as new therapeutic options. Calcium absorption from intestinal cells occurs by transcellular path and paracellular path. Transcellular absorption occurs ...